Every round on record, with the sources behind each and the investors on them.
A startup developing the investigational HELYX-PE System
flowmedical.coChicagoMedtech
2 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The announced seed round includes $2 million previously secured from friends and family; no separate named friends-and-family investors are identified.
3 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
2 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The article separately says Flow Medical was completing an initial seed round requiring $3 million; it does not explicitly identify the announced $1 million investment as that round or name the device manufacturer.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $5M | 2024-12-17 | not stated | No recent discussion |
2 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 sources
The announced seed round includes $2 million previously secured from friends and family; no separate named friends-and-family investors are identified. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: flowmedical.co, venousnews.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources·[ AGENT ]company research by the Firecrawl agent | ||||
| Friends and Family funding round Friends and Family funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2M | 2023-12-12 | not stated | No recent discussion |
3 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 of 3 sources
| ||||
| Seed [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1M $3M to date | 2023-06-15 | not stated | No recent discussion |
2 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 2 sources
The article separately says Flow Medical was completing an initial seed round requiring $3 million; it does not explicitly identify the announced $1 million investment as that round or name the device manufacturer. | ||||
Flow Medical is developing the investigational HELYX-PE catheter system for clinicians treating pulmonary embolism, combining clot-busting drug delivery with angiography and continuous pulmonary-artery pressure monitoring.
Flow Medical is addressing a documented gap in pulmonary-embolism care: physicians currently cannot precisely tell when catheter-directed thrombolysis has worked or should stop, and many patients eligible for catheter intervention receive only anticoagulation and monitoring. Its investigational HELYX-PE System combines an expandable infusion scaffold, drug delivery, angiography and continuous pulmonary-artery pressure monitoring, while the latest reported $6 million round is intended to fund first-in-human evaluation, product and manufacturing work, and preparation for pivotal and FDA studies.
Checked against 10 sources today
Also named as backers in company research: UCM Ventures, University of Chicago Medical Center, National Institutes of Health SBIR program, Compass deep tech accelerator, Polsky Center for Entrepreneurship and Innovation